ABSTRACT

The present study aimed to evaluate the effectiveness and reliability of titanium-platelet-rich fibrin (T-PRF) autograft implantation in patients who underwent this treatment method.

Our study included patients who underwent titanium-platelet-rich membrane autograft implantation at our clinic for the management of primary pterygium. Demographic characteristics of patients, size of the pterygium as determined during pre- and postoperative biomicroscopic examinations, presence of granulation tissue, recurrence, corneal, and other complications, condition of the implanted graft, and conjunctival epithelization were evaluated. The absence of recurrence was considered as a criterion of success.

Twelve eyes belonging to total 12 patients (men, 5 and women, 7) with a mean age of 52.1±12.6 (range, 30–75) years and mean followup period of 2.91±1.37 (range, 1–5) months were included in the study. The follow-up period of total 8 cases exceeded 3 months. Recurrence was observed in 2 (16.6%) cases.

Because no complications were oberved our study, this new surgical technique was considered reliable. Based on our preliminary reports, T-PRF autograft technique can be used as an alternative to other surgical techniques.

Keywords: Titanium-platelet-rich fibrin, autograft, pterygium